When a survey was distributed to students, faculty and staff of a dental school to determine the incidence of latex glove reactions, 15 percent reported adverse reactions to glove use. The most frequently reported symptom was dermatitis, followed by urticaria, sweating, conjunctivitis and rhinitis.

This article has been cited by other articles:

				A. Weinberg, M.E. Quinones-Mateu, and M.M. Lederman Role of Human {beta}-defensins in HIV Infection Adv. Dent. Res., April 1, 2006; 19(1): 42 - 48. [Abstract] [Full Text] [PDF]

				M.C. Herzberg, A. Weinberg, and S.M. Wahl (C3) The Oral Epithelial Cell and First Encounters with HIV-1 Adv. Dent. Res., April 1, 2006; 19(1): 158 - 166. [Abstract] [Full Text] [PDF]

				K. L. Wood, P. Chaiyarit, R. B. Day, Y. Wang, C. T. Schnizlein-Bick, R. L. Gregory, and H. L. Twigg III Measurements of HIV Viral Loads From Different Levels of the Respiratory Tract Chest, August 1, 2003; 124(2): 536 - 542. [Abstract] [Full Text] [PDF]

				K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 725 - 745. [Abstract] [Full Text] [PDF]

				A. A. M. A. Baqui, T. F. Meiller, and W. A. Falkler Jr. Enhanced Secretory Leukocyte Protease Inhibitor in Human Immunodeficiency Virus Type 1-Infected Patients Clin. Vaccine Immunol., November 1, 1999; 6(6): 808 - 811. [Abstract] [Full Text] [PDF]

				S. Baron, J. Poast, and M. W. Cloyd Why Is HIV Rarely Transmitted by Oral Secretions?: Saliva Can Disrupt Orally Shed, Infected Leukocytes Arch Intern Med, February 8, 1999; 159(3): 303 - 310. [Abstract] [Full Text] [PDF]

				R. Crombie, R. L. Silverstein, C. MacLow, S. F. A. Pearce, R. L. Nachman, and J. Laurence Identification of a CD36-related Thrombospondin 1-binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1-specific Inhibitory Factors in Human Saliva J. Exp. Med., January 5, 1998; 187(1): 25 - 35. [Abstract] [Full Text] [PDF]

				T. B. McNeely, D. C. Shugars, M. Rosendahl, C. Tucker, S. P. Eisenberg, and S. M. Wahl Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by Secretory Leukocyte Protease Inhibitor Occurs Prior to Viral Reverse Transcription Blood, August 1, 1997; 90(3): 1141 - 1149. [Abstract] [Full Text] [PDF]

				D. H. Coppenhaver, P. Sriyuktasuth-Woo, S. Baron, C. E. Barr, and M. N. Qureshi Correlation of Nonspecific Antiviral Activity with the Ability to Isolate Infectious Hiv-1 from Saliva N. Engl. J. Med., May 5, 1994; 330(18): 1314 - 1315. [Full Text]